methoxyhydroxyphenylglycol has been researched along with Chronic Disease in 38 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (47.37) | 18.7374 |
1990's | 9 (23.68) | 18.2507 |
2000's | 5 (13.16) | 29.6817 |
2010's | 6 (15.79) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, SH; Ruan, HZ; Shen, LL; Wen, HZ; Zhao, YD | 1 |
Brown, AD; Galatzer-Levy, IR; Henn-Haase, C; Inslicht, S; Marmar, CR; Neylan, TC; Otte, C; Qian, M; Steenkamp, MM; Yehuda, R | 1 |
Atake, K; Hori, H; Igata, R; Katsuki, A; Konishi, Y; Nakamura, J; Yoshimura, R | 1 |
Chattarji, S; Das, R; Sengupta, T | 1 |
Ozawa, N; Shinba, T; Yamamoto, K; Yoshii, M | 1 |
Anisman, H; Audet, MC; McQuaid, RJ | 1 |
Cannon, RO; Dendi, R; Eisenhofer, G; Esler, MD; Frank, SM; Goldstein, DS; Holmes, C; Sharabi, Y | 1 |
Goldstein, DS; Holmes, C; Kopin, IJ; Patronas, N | 1 |
Freeman, R; Goldstein, DS; Holmes, C; Kaufmann, H | 1 |
Aksu, F; Belzung, C; Bodard, S; Chalon, S; Yalcin, I | 1 |
Chen, YF | 1 |
Cooper, SJ; King, DJ; Liddle, J | 1 |
Bartfai, A; Levander, SE; Sedvall, G | 1 |
Bartko, J; Chang, WH; Linnoila, M; Ninan, PT; Scheinin, M; van Kammen, DP; Waters, RN | 1 |
Jimerson, DC; Kopin, IJ; Polinsky, RJ | 1 |
Hoaki, Y; Ida, Y; Kohno, Y; Nishikawa, T; Tanaka, M | 1 |
Armario, A; Campmany, L; Pol, O | 1 |
Inanaga, K; Kuniyoshi, M; Miura, C; Nakamura, J | 1 |
Fleischhaker, C; Remschmidt, H; Schulz, E | 1 |
Adler, LE; Baker, N; Cawthra, E; Dubester, S; Madison, A; Nagamoto, H; Scherzinger, A; Simon, J; Staunton, M; Waldo, MC | 1 |
Elkashef, AM; Green, JP; Jaeger, AC; Kaufmann, CA; Khandelwal, JK; Kirch, DG; Lawson, WB; Linnoila, M; Prell, GD; Wyatt, RJ | 1 |
Fukuda, M; Hata, A; Hiramatsu, K; Honda, H; Iwanami, A; Nakagome, K; Niwa, S | 1 |
Gilbertson, MW; Gurklis, JA; Inosaka, T; Kelley, ME; Peters, JL; Saito, H; Sato, M; van Kammen, DP; Yao, JK | 1 |
Archer, T; Kjellgren, A; Norlander, T; Sundequist, U | 1 |
Mitsunobu, K; Nagao, T; Ohshimo, T; Otsuki, S; Sato, M | 1 |
Baker, HF; Deakin, JF; Frith, CD; Johnstone, EC; Joseph, MH | 1 |
Cytryn, L; McKnew, DH | 1 |
Subrahmanyam, S | 1 |
Anokhina, IP; Kogan, BM | 1 |
Armando, I; Fukuhara, K; Goldstein, DS; Kopin, IJ; Kvetnansky, R; Pacak, K; Palkovits, M | 1 |
Imai, T; Kai, S; Kajimura, N; Kaneyuki, H; Mizuki, Y; Suetsugi, M; Yamada, M | 1 |
Linnoila, M; Mazonson, A; Ninan, P; Paul, SM; Pickar, D; Roy, A; Van Kammen, D | 1 |
Almay, BG; Johansson, F; Sakurada, T; Terenius, L; von Knorring, L | 1 |
Curtis, DA; Stibbs, HH | 1 |
Goetz, KL; Linnoila, M; Nugent, A; Peters, J; van Kammen, DP; van Kammen, WB; Yao, J | 1 |
Hodsman, GP; Howes, LG; Johnston, CI; Rowe, PR; Sumithran, E | 1 |
Costich, JF; Engelberg, J; Humphries, LL; Marciani, RD; Maxwell, EN; Wiegert, T | 1 |
Cytryn, L; Desai, RB; Logue, M; McKnew, DH | 1 |
6 trial(s) available for methoxyhydroxyphenylglycol and Chronic Disease
Article | Year |
---|---|
Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Autonomic Nervous System Diseases; Chronic Disease; Coronary Circulation; Dihydroxyphenylalanine; Dopamine; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Hypotension, Orthostatic; Lower Body Negative Pressure; Male; Methoxyhydroxyphenylglycol; Myocardium; Norepinephrine; Reference Values; Sympathetic Nervous System; Syncope, Vasovagal; Syndrome; Tachycardia; Tomography, Emission-Computed; Yohimbine | 2002 |
Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Blood Pressure; Catecholamines; Chronic Disease; Diet; Droxidopa; Female; Half-Life; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 2004 |
The effect of propranolol on CSF amine metabolites in psychiatric patients.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates; Propranolol; Schizophrenia | 1983 |
Predicting haloperidol treatment response in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1996 |
Effects of flotation-REST on muscle tension pain.
Topics: Adult; Anxiety; beta-Endorphin; Chronic Disease; Depression; Female; Headache; Humans; Male; Methoxyhydroxyphenylglycol; Muscle Contraction; Pain; Pain Management; Personality; Psychophysiologic Disorders; Relaxation Therapy; Reproducibility of Results; Sleep | 2001 |
Biochemical correlates of affective disorders in children.
Topics: Acute Disease; Adult; Affective Symptoms; Age Factors; Brain; Child; Chronic Disease; Clinical Trials as Topic; Depression; Female; Glycols; Hospitalization; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Vanilmandelic Acid | 1974 |
32 other study(ies) available for methoxyhydroxyphenylglycol and Chronic Disease
Article | Year |
---|---|
Inhibition of Metabotropic Glutamate Receptor Subtype 1 Alters the Excitability of the Commissural Pyramidal Neuron in the Rat Anterior Cingulate Cortex after Chronic Constriction Injury to the Sciatic Nerve.
Topics: Animals; Behavior, Animal; Blotting, Western; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; Down-Regulation; Fluorescent Antibody Technique; Gyrus Cinguli; Male; Methoxyhydroxyphenylglycol; Neuralgia; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Sciatic Nerve | 2017 |
Cortisol response to an experimental stress paradigm prospectively predicts long-term distress and resilience trajectories in response to active police service.
Topics: Adult; Chronic Disease; Female; Humans; Hydrocortisone; Logistic Models; Male; Methoxyhydroxyphenylglycol; Neuropsychological Tests; Police; Prospective Studies; Resilience, Psychological; Saliva; Stress, Psychological; Surveys and Questionnaires; Urban Population; Video Recording | 2014 |
Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Topics: Adult; Antipsychotic Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Case-Control Studies; Chronic Disease; Cognition; Cytokines; Female; Homovanillic Acid; Humans; Intelligence Tests; Japan; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Young Adult | 2017 |
Chronic but not acute immobilization stress stably enhances hippocampal CA1 metabotropic glutamate receptor dependent Long-Term Depression.
Topics: Acute Disease; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Chronic Disease; Immobilization; Long-Term Synaptic Depression; Male; Methoxyhydroxyphenylglycol; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stress, Psychological; Synapses; Time Factors | 2016 |
Delayed increase of brain noradrenaline after acute footshock stress in rats.
Topics: Acute Disease; Animals; Brain Chemistry; Cerebral Cortex; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Electroshock; Foot; Hippocampus; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Wistar; Spectrometry, Fluorescence; Stress Disorders, Post-Traumatic; Stress, Psychological | 2010 |
Environmental enrichment in male CD-1 mice promotes aggressive behaviors and elevated corticosterone and brain norepinephrine activity in response to a mild stressor.
Topics: Aggression; Animals; Behavior, Animal; Brain Chemistry; Chronic Disease; Corticosterone; Data Interpretation, Statistical; Environment; Hippocampus; Interpersonal Relations; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Prefrontal Cortex; Stress, Psychological | 2012 |
Cerebrospinal fluid levels of catechols in patients with neurogenic orthostatic hypotension.
Topics: Aged; Alzheimer Disease; Autonomic Nervous System Diseases; Case-Control Studies; Catechols; Chronic Disease; Humans; Hypotension, Orthostatic; Linear Models; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Norepinephrine | 2003 |
Antidepressant-like effect of tramadol in the unpredictable chronic mild stress procedure: possible involvement of the noradrenergic system.
Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Cerebellum; Chronic Disease; Desipramine; Hippocampus; Hypothalamus; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred BALB C; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta-2; Stress, Psychological; Tramadol | 2007 |
[Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Topics: Adult; Antipsychotic Agents; Biogenic Amines; Chronic Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Probenecid; Schizophrenia | 1984 |
Smooth pursuit eye movements, clinical symptoms, CSF metabolites, and skin conductance habituation in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Eye Movements; Female; Galvanic Skin Response; Habituation, Psychophysiologic; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Schizophrenia | 1983 |
Reliability of norepinephrine and major monoamine metabolite measurements in CSF of schizophrenic patients.
Topics: Adult; Chronic Disease; Female; Glycols; Homovanillic Acid; Hospitalization; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Phenylacetates; Schizophrenia; Schizophrenic Psychology; Spinal Puncture; Time Factors | 1983 |
Chronic autonomic failure: CSF and plasma 3-methoxy-4-hydroxyphenylglycol.
Topics: Adult; Aged; Atrophy; Autonomic Nervous System Diseases; Chronic Disease; Female; Glycols; Humans; Hypotension, Orthostatic; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 1984 |
Effect of haloperidol administration on serum MHPG-SO4 levels in chronic schizophrenics.
Topics: Adult; Biotransformation; Brain; Chronic Disease; Glycols; Haloperidol; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia | 1981 |
Inhibition of catecholamine synthesis with alpha-methyl-p-tyrosine apparently increases brain serotoninergic activity in the rat: no influence of previous chronic immobilization stress.
Topics: Acute Disease; alpha-Methyltyrosine; Animals; Brain Chemistry; Catecholamines; Chronic Disease; Enzyme Inhibitors; Hydroxyindoleacetic Acid; Immobilization; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Stress, Psychological; Tyrosine 3-Monooxygenase | 1995 |
Effectiveness of concomitant setiptiline maleate (Tecipul) on negative symptoms of schizophrenia.
Topics: Adult; Biogenic Monoamines; Chronic Disease; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists | 1994 |
[Effect of clozapine on biogenic amines within the scope of drug treatment of schizophrenic psychoses in adolescence].
Topics: Adolescent; Adult; Antipsychotic Agents; Chronic Disease; Clozapine; Depressive Disorder; Dopamine; Epinephrine; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Serotonin; Treatment Outcome | 1994 |
Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings.
Topics: Acoustic Stimulation; Adult; Amygdala; Arousal; Attention; Catecholamines; Chronic Disease; Dopamine; Evoked Potentials, Auditory; Female; Habituation, Psychophysiologic; Hippocampus; Homovanillic Acid; Humans; Magnetic Resonance Imaging; Male; Methoxyhydroxyphenylglycol; Neural Inhibition; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Vanilmandelic Acid | 1994 |
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Biogenic Amines; Chronic Disease; Drinking; Female; Histamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methylhistamines; Middle Aged; Norepinephrine; Polyuria; Reference Values; Schizophrenia; Water-Electrolyte Balance | 1996 |
Exaggerated responsivity of brain dopaminergic system activity in schizophrenia: a preliminary finding of increased variance of plasma homovanillic acid level in a chronic patient.
Topics: Adult; Brain; Chronic Disease; Dopamine; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Vanilmandelic Acid | 1996 |
Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor.
Topics: Adult; Chronic Disease; Cyclic AMP; Cyclic GMP; Cyproheptadine; Dyskinesia, Drug-Induced; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Schizophrenia; Tremor; Valproic Acid | 1979 |
Arousal related to excretion of noradrenaline metabolites and clinical aspects of unmedicated chronic schizophrenic patients.
Topics: Aged; Arousal; Chronic Disease; Galvanic Skin Response; Habituation, Psychophysiologic; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Schizophrenia; Schizophrenic Psychology; Vanilmandelic Acid | 1979 |
Urinary metabolites in chronically depressed children.
Topics: Child; Chronic Disease; Depression; Female; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Vanilmandelic Acid | 1979 |
Role of biogenic amines in certain pathological conditions.
Topics: Acute Disease; Adult; Aggression; Biogenic Amines; Bipolar Disorder; Chlorpromazine; Chronic Disease; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Imipramine; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Nialamide; Schizophrenia | 1975 |
[The role of disorders in the functions of the cerebral catecholamine system in the pathogenesis of chronic alcoholism].
Topics: Alcoholic Intoxication; Alcoholism; Brain; Catecholamines; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Electroencephalography; Humans; Hypothalamus; Mesencephalon; Methoxyhydroxyphenylglycol; Norepinephrine; Normetanephrine | 1975 |
Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Animals; Chronic Disease; Dialysis; Disease Models, Animal; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Paraventricular Hypothalamic Nucleus; Random Allocation; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological | 1992 |
Effects of mianserin on negative symptoms in schizophrenia.
Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Brain; Chronic Disease; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mianserin; Middle Aged; Psychiatric Status Rating Scales; Receptors, Dopamine; Schizophrenia; Schizophrenic Psychology | 1990 |
CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide.
Topics: Adult; Chronic Disease; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Phenylacetates; Risk; Schizophrenia; Schizophrenic Psychology; Suicide, Attempted | 1985 |
Long-term high frequency transcutaneous electrical nerve stimulation (hi-TNS) in chronic pain. Clinical response and effects on CSF-endorphins, monoamine metabolites, substance P-like immunoreactivity (SPLI) and pain measures.
Topics: Adult; Aged; Chronic Disease; Electric Stimulation Therapy; Endorphins; Female; Follow-Up Studies; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Pain; Pain Management; Phenylacetates; Radioimmunoassay; Substance P; Transcutaneous Electric Nerve Stimulation | 1985 |
Neurochemical changes in experimental African trypanosomiasis in voles and mice.
Topics: Animals; Arvicolinae; Brain; Chronic Disease; Dopamine; Female; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Serotonin; Trypanosomiasis, African | 1987 |
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Psychiatric Status Rating Scales; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome | 1989 |
Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Catecholamines; Chronic Disease; Female; Glycols; Indoles; Methoxyhydroxyphenylglycol; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Rats; Rats, Inbred Strains | 1989 |
Chronic pain: economic, psychosocial, ethical, preventive, and medical aspects.
Topics: Adolescent; Chronic Disease; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Father-Child Relations; Humans; Hydrocortisone; Imipramine; Male; Methoxyhydroxyphenylglycol; Mother-Child Relations; Orthodontic Appliances; Pain; Psychotherapy | 1985 |